Geert Cauwenbergh
Overview
Geert Cauwenbergh received an average of $699K in total compensation, including $286K in salary, at RXi Pharmaceuticals from 2012 to 2022.
2022RXi PharmaceuticalsFormer interim Principal Executive and Financial Officer
2021RXi PharmaceuticalsFormer interim Principal Executive and Financial Officer
2019RXi PharmaceuticalsFormer Chief Executive Officer
2018RXi PharmaceuticalsFormer Chief Executive Officer
2017RXi PharmaceuticalsPresident, Chief Executive Officer and acting Chief Financial Officer
2016RXi PharmaceuticalsPresident, Chief Executive Officer and acting Chief Financial Officer
2015RXi PharmaceuticalsPresident, Chief Executive Officer and acting Chief Financial Officer
2014RXi PharmaceuticalsPresident, Chief Executive Officer and acting Chief Financial Officer
2013RXi PharmaceuticalsPresident and Chief Executive Officer
2012RXi PharmaceuticalsPresident and Chief Executive Officer
Source: SEC filings on June 9, 2023, August 28, 2020, August 30, 2019, April 26, 2018, April 27, 2017, November 4, 2016, April 16, 2015, and April 15, 2014.
Related executives
We found six more executives who work or worked at RXi Pharmaceuticals.
Gerrit Dispersyn
RXi Pharmaceuticals
Chief Executive Officer
Robert Bitterman
RXi Pharmaceuticals
Chief Executive Officer
John Barrett
RXi Pharmaceuticals
Former Chief Development Officer
Alexey Eliseev
RXi Pharmaceuticals
Former Chief Business Officer
Pamela Pavco
RXi Pharmaceuticals
Former Chief Development Officer
Anastasia Khvorova
RXi Pharmaceuticals